| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |